Modafinil is a wakefulness-promoting agent that selectively targets neuronal pathways in the sleep/wake centers of the brain. In placebo-controlled clinical trials, it improved objectively determined wakefulness (MSLT and ESS scores) and reduced patient-reported sleepiness compared with placebo after 4 weeks. It was also well tolerated in these double-blind placebo-controlled studies and...